Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers
Emadali A, Rousseaux S, Bruder-Costa J, Rome C, Duley S, Hamaidia S, Betton P, Debernardi…
EMBO Mol Med 2013 Aug;5(8):1180-95. doi:10.1002/emmm.201202034. Epub 2013 Jul 4. PMID: 23828858; PMCID: PMC3944460.